What is the purpose of this medication?

Bamlanivimab injection is used to treat COVID-19 infection in adults and children 12 years of age and older who are not hospitalised and weigh at least 88 pounds (40 kg) who have mild to moderate COVID-19 symptoms. It is prescribed to persons who have specific medical problems that put them at a higher risk of having severe COVID-19 symptoms or needing to be hospitalised as a result of COVID-19 infection. Bamlanivimab belongs to a family of drugs known as monoclonal antibodies. It works by preventing the spread of the virus by inhibiting the function of a natural substance in the body.


How should this medication be administered?

Bamlanivimab is available as a solution (liquid) that must be combined with fluids before being injected gently into a vein over the course of 60 minutes by a doctor or nurse. It is administered as a single dosage as soon as feasible after a positive COVID-19 test and within 10 days after the onset of COVID-19 infection symptoms such as fever, cough, or shortness of breath.


During and after the infusion of the medicine, bamlanivimab injection may produce significant or life-threatening responses. A doctor or nurse will closely monitor you while you are getting the drug and for at least 1 hour thereafter. If you experience any of the following symptoms during or after the infusion, contact your doctor or nurse immediately: fever, chills, nausea, headache, shortness of breath; high or low blood pressure; slow or fast heartbeat; chest pain or discomfort; weakness; confusion; tiredness; wheezing; rash, hives, or itching; muscle aches or pain; dizziness; sweating; or swelling of the face, throat, tongue, or lips. If you encounter any of these adverse effects, your doctor may need to scale down or stop your therapy.

Request a copy of the manufacturer’s information for the patient from your chemist or doctor.

Other use for this medication

This drug may also be recommended for other purposes; consult your doctor or chemist for additional details.

What further measures should I take?

Tell your doctor and chemist if you are allergic to bamlanivimab, any other drugs, or any of the chemicals in bamlanivimab injection before getting it. Request a list of the components from your chemist.
Inform your doctor and chemist about any additional prescription and nonprescription drugs, vitamins, nutritional supplements, and herbal items you are now taking or intend to use. Your doctor may need to adjust the dosage of your drugs or closely monitor you for adverse effects.
Inform your doctor and chemist about any additional prescription and nonprescription drugs, vitamins, nutritional supplements, and herbal items you are now taking or intend to use. Immunosuppressive drugs such as cyclosporine (Gengraf, Neoral, Sandimmune), prednisone, and tacrolimus (Astagraf, Envarsus, Prograf) should be mentioned. Your doctor may need to adjust the dosage of your drugs or closely monitor you for adverse effects.

Inform your doctor if you have or have ever had any medical problems.
Inform your doctor if you are pregnant, want to become pregnant, or are nursing. Call your doctor if you become pregnant while taking bamlanivimab.

READ MORE: Bamlanivimab and Etesevimab Injection-Uses-Side-Effects-Dosage-Interactions-Reviews

What dietary restrictions should I observe?

Continue to eat normally unless your doctor instructs you differently.

What are the potential Side effects of this medication?

Bamlanivimab may have unwanted side effects. Inform your doctor if any of the following symptoms are severe or persistent:
bleeding, bruising, pain, soreness, or swelling at injection site
Some side effects can be serious. If you experience any of these symptoms or those in the HOW section, call your doctor immediately or get emergency medical treatment.
difficulty breathing
changes in heart rate
tiredness or weakness
Other Side effects of bamlanivimab injection are possible. If you have any odd side effects while taking this medicine, contact your doctor.

If you have a significant adverse event, you or your doctor can report it to the FDA’s MedWatch Adverse Event Reporting programme online ( or by phone (1-800-332-1088).

What else should I be aware of?

Keep all of your doctor’s visits.

Any inquiries concerning bamlanivimab injection should be directed to your chemist.

Continue to isolate as recommended by your doctor and adhere to public health practises like as wearing a mask, social distance, and frequent hand washing.

It is critical that you keep a written record of all prescription and nonprescription (over-the-counter) medications you are taking, as well as any vitamins, minerals, or other dietary supplements. You should carry this list with you whenever you go to the doctor or are admitted to the hospital. It is also crucial to have this information on hand in case of an emergency.

The American Society of Health-System Pharmacists, Inc. asserts that this data concerning bamlanivimab was crafted with a reasonable level of care and adherence to professional benchmarks in the field. It is important to note that bamlanivimab is not an approved remedy for COVID-19 caused by SARS-CoV-2; instead, it is under investigation and presently accessible through an FDA emergency use authorization (EUA) for addressing mild to moderate COVID-19 in particular outpatients. The American Society of Health-System Pharmacists, Inc. does not make any explicit or implicit guarantees, encompassing but not confined to any inferred assurance of marketability and/or suitability for a specific objective, regarding the information and explicitly renounces all such guarantees. Those reading the bamlanivimab details are advised that ASHP is not liable for ensuring the continuing currency of the information, for any errors or exclusions, and/or for any outcomes resulting from the utilization of this information. Readers are cautioned that choices concerning pharmaceutical treatment are intricate medical determinations that demand the autonomous, well-informed choice of a suitable healthcare professional, and the data within this material is furnished solely for informative intentions. The American Society of Health-System Pharmacists, Inc. does not support or propose the application of any medication. This insight about bamlanivimab should not be construed as individual patient counsel. Because of the dynamic nature of drug information, it is recommended to consult your physician or pharmacist regarding the precise clinical application of any and all medications.

Leave a Reply

Your email address will not be published. Required fields are marked *